Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A multicenter phase II trial
在接受曲妥珠单抗辅助治疗的 HER2 阳性乳腺癌患者中应用吡咯替尼(PERSIST):一项多中心 II 期试验
期刊:Elife
影响因子:6.4
doi:10.7554/eLife.101724
Cao, Feilin; Ma, Zhaosheng; Wu, Zenggui; Wu, Weizhu; Wang, Ouchen; Cui, Binbin; Zhu, Xiaotao; Hao, Jing; Ji, Xiaochun; Li, Zhanwen; Tao, Deyou; Feng, Qingjing; Lin, Wei; Shi, Dongbo; Shu, Jingde; Zhou, Jichun; Huang, Shifen